BURIONI, ROBERTO
 Distribuzione geografica
Continente #
EU - Europa 4.732
NA - Nord America 4.245
AS - Asia 3.613
SA - Sud America 977
Continente sconosciuto - Info sul continente non disponibili 177
AF - Africa 83
OC - Oceania 11
Totale 13.838
Nazione #
US - Stati Uniti d'America 4.004
RU - Federazione Russa 2.345
SG - Singapore 1.329
CN - Cina 1.149
IT - Italia 973
BR - Brasile 779
SE - Svezia 638
HK - Hong Kong 440
VN - Vietnam 353
FR - Francia 200
DE - Germania 144
CA - Canada 125
GB - Regno Unito 114
AR - Argentina 82
FI - Finlandia 73
IN - India 68
NL - Olanda 63
BD - Bangladesh 62
PL - Polonia 40
EC - Ecuador 38
MX - Messico 38
ZA - Sudafrica 33
ID - Indonesia 29
ES - Italia 28
AT - Austria 27
CO - Colombia 27
JP - Giappone 27
IQ - Iraq 23
IE - Irlanda 22
TR - Turchia 17
SA - Arabia Saudita 15
JM - Giamaica 14
PY - Paraguay 14
UZ - Uzbekistan 14
RO - Romania 13
UA - Ucraina 13
CL - Cile 11
LT - Lituania 11
NP - Nepal 11
PH - Filippine 11
CR - Costa Rica 10
PK - Pakistan 10
TT - Trinidad e Tobago 10
HN - Honduras 9
MA - Marocco 9
TN - Tunisia 9
VE - Venezuela 9
AU - Australia 8
EG - Egitto 8
MY - Malesia 8
PE - Perù 8
KE - Kenya 7
NI - Nicaragua 7
UY - Uruguay 7
IR - Iran 6
AE - Emirati Arabi Uniti 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
BH - Bahrain 4
CZ - Repubblica Ceca 4
GT - Guatemala 4
PR - Porto Rico 4
SV - El Salvador 4
AZ - Azerbaigian 3
GA - Gabon 3
IL - Israele 3
JO - Giordania 3
KZ - Kazakistan 3
NZ - Nuova Zelanda 3
TH - Thailandia 3
TW - Taiwan 3
BE - Belgio 2
BG - Bulgaria 2
BO - Bolivia 2
BS - Bahamas 2
BY - Bielorussia 2
DK - Danimarca 2
GD - Grenada 2
GE - Georgia 2
GP - Guadalupe 2
IS - Islanda 2
KW - Kuwait 2
MD - Moldavia 2
MU - Mauritius 2
QA - Qatar 2
RS - Serbia 2
SC - Seychelles 2
SI - Slovenia 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BZ - Belize 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DM - Dominica 1
EU - Europa 1
GR - Grecia 1
HR - Croazia 1
KG - Kirghizistan 1
Totale 13.647
Città #
Dallas 657
Ashburn 622
Singapore 540
Moscow 488
Hong Kong 437
San Jose 437
Milan 241
Shanghai 240
Council Bluffs 205
Hefei 180
Princeton 171
Lawrence 168
Lauterbourg 155
Beijing 146
Ho Chi Minh City 131
New York 122
Los Angeles 77
São Paulo 72
Hanoi 68
Santa Clara 63
Phoenix 59
Helsinki 55
Rome 48
Orem 41
Miano 40
London 36
Warsaw 34
Bologna 33
Montreal 33
Munich 33
Atlanta 29
Chennai 29
Nuremberg 28
Toronto 28
Chicago 26
Rio de Janeiro 25
Bari 23
Johannesburg 23
Stockholm 23
Dublin 22
Ancona 21
Naples 21
Seattle 21
Tokyo 21
Boardman 20
Brasília 19
Brooklyn 19
Turin 19
Guangzhou 18
Poplar 18
Boston 17
Mexico City 17
Amsterdam 16
Brescia 16
Denver 16
Washington 16
Biên Hòa 15
Quito 15
Belo Horizonte 14
Da Nang 14
Shenzhen 13
Falkenstein 12
Haiphong 12
Hangzhou 12
Houston 12
Pune 12
Tashkent 12
Tianjin 12
Turku 12
Catania 11
Frankfurt am Main 11
Guayaquil 11
Manchester 11
San Francisco 11
Curitiba 10
Vienna 10
Ankara 9
Florence 9
Guarulhos 9
Ninh Bình 9
Santo André 9
Sorocaba 9
The Bronx 9
Calgary 8
Columbus 8
Jeddah 8
Kingston 8
Manaus 8
Marino 8
Porto Alegre 8
Salvador 8
Verona 8
Asunción 7
Bogotá 7
City of London 7
Managua 7
Milwaukee 7
Nairobi 7
Trento 7
Campinas 6
Totale 6.615
Nome #
Salute : Le frontiere della medicina : Volumi dedicati alla Salute a cura di Roberto Burioni 295
A Human Stem Cell-Derived Neurosensory–Epithelial Circuitry on a Chip to Model Herpes Simplex Virus Reactivation 244
Virus, la grande sfida : dal coronavirus alla peste : come la scienza può salvare l'umanità / Roberto Burioni ; con la collaborazione di Pier Luigi Lopalco 236
Evaluation of respiratory virus transmissibility and resilience from fomites: the case of 11 SARS-CoV-2 clinical isolates 207
Trends of Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates between 2012 and 2023: Results from an Open Italian Cohort 148
A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments 141
A Biologically-validated HCV E1E2 Heterodimer Structural Model 141
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects 140
Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: Epitope definition and implications in risk stratification of patients under natalizumab therapy 139
Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection 139
A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes 138
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro 138
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses 132
A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza 122
ANTI-HIV-1 RESPONSE ELICITED IN RABBITS BY ANTI-IDIOTYPE MONOCLONAL ANTIBODIES MIMICKING THE CD4-BINDING SITE ON GP120 121
Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections 119
A vector for the expression of recombinant monoclonal Fab fragments in bacteria 117
Bacteriophages and Their Immunological Applications against Infectious Threats 117
Single spike mutation differentiating XBB.1 and XBB.1.5 enhances SARS-CoV-2 cell-to-cell transmission and facilitates serum-mediated enhancement 116
Rectal Lymphogranuloma venereum among Men who Have Sex with Men: 7 versus 21 Days Doxycycline Effectiveness 113
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes 113
Differential composition of vaginal microbiome, but not of seminal microbiome, is associated with successful intrauterine insemination in couples with idiopathic infertility: A prospective observational study 110
Acute respiratory distress in a neutropenic febrile patient after hematopoietic cell transplantation 109
A closer look at prion strains: Characterization and important implications 109
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion? 108
Adaptive immunity against gut microbiota enhances apoE-mediated immune regulation and reduces atherosclerosis and western-diet-related inflammation 107
A recombinant human Fab inhibits helicase activity of HCVNS3 and negative strand RNA synthesis 105
IN VIVO PROTECTION CONFERRED BY HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST HSV-1 AND 2 105
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols 105
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine 104
Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site 103
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge 103
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein 103
Heterosubtypic protection conferred by the human monoclonal antibody PN-SIA28 against influenza A virus lethal infections in mice 102
A novel expression vector for production of epitope-tagged recombinant Fab-fragment in bacteria 102
Major sports events and the transmission of sars-cov-2: Analysis of seven case-studies in europe 101
A recombinant human Fab inhibits activity of HCVNS3 and negative strand RNA synthesis 100
Structural basis for a human broadly neutralizing influenza A hemagglutinin stem-specific antibody including H17/18 subtypes 98
A recombinant human Fab inhibits helicase activity of HCVNS3 and negative strand RNA synthesis 97
A novel efflux system in inducibly erythromycin-resistant strains of Streptococcus pyogenes 96
SARS-CoV-2 before and after Omicron: two different viruses and two different diseases? 95
"Freezing" parasites in pre-Himalayan region, Himachal Pradesh: Experience with mini-FLOTAC 95
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects 94
63. Vaccini Antivirali 93
Answer to February 2019 Photo Quiz: Neurological Symptoms in a 74-Year-Old Diabetic Woman Admitted to the Emergency Room 93
Match point. Come la scienza sta sconfiggendo il cancro 92
Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques 91
A NEW PLASMID CLONING VECTOR FOR DIRECT-DETECTION OF RECOMBINANT CLONES, BASED ON INACTIVATION OF A BACTERIAL ACID PHOSPHATASE-ENCODING GENE 91
Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity 91
Characterization of two human monoclonal anti-E2/HCV antibodies for potential application in prevention and treatment of HCV infection 90
Epitope mapping by epitope excision, hydrogen/deuterium exchange, and peptide-panning techniques combined with in silico analysis 90
Role and potential therapeutic use of antibodies against herpetic infections 89
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines 88
36. Meccanismi difensivi dell'ospite alle infezioni virali 88
A new subtraction technique for molecular cloning of rare antiviral antibody specificities from phage display libraries 87
66. Vaccini antivirali 86
Assessing the human immune response to SARS-CoV-2 variants 85
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools 84
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome 84
HCV E2 core structures and mAbs: something is still missing 83
Virus-induced preferential antibody gene-usage and its importance in humoral autoimmunity 77
39 Meccanismi difensivi dell'ospite alle infezioni virali 77
HUMAN MONOCLONAL ANTIBODY ENDOWED WITH ANTI-HSV-1 AND -2 ACTIVITY STRONGLY INHIBITS VIRUS REPLICATION 76
Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies 76
Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV) 75
Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens 75
Microbiological Diagnosis of Sepsis: The Confounding Effects of a “Gold Standard” 74
Has SARS-CoV-2 reached peak fitness? 74
Il vaccino non è un'opinione. Le vaccinazioni spiegate a chi proprio non le vuole capire 71
Anti-HCV monoclonal antibody as a medicament for the therapeutic treatment and prevention of HCV infections 70
Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemia 70
Phage display for the production of human monoclonal antibodies against human pathogens 69
Photo quiz: Neurological symptoms in a 74-year-old diabetic woman admitted to the emergency room 69
Method for the preparation of new oligoclonal antibodies 68
Humoral immune response against hepatitis C virus 68
Anti-idiotype monoclonal antibodies as mimotopes of the HIV gp120 antigen 67
Risks of "blind" automated identification systems in medical microbiology 67
Direct sequencing of Scedosporium apiospermum DNA in the diagnosis of a case of keratitis 67
Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle 66
Cross-reactive pseudovirus-neutralizing anti-envelope antibodies coexist with antibodies devoid of such activity in persistent hepatitis C virus infection 65
Monoclonal antibodies having homosubtype cross-neutralization properties against influenza A viruses subtype H1 65
Comparative Evaluation of the Bruker Biotyper and Vitek MS Matrix-Assisted Laser Desorption Ionization–Time Of Flight (MALDI-TOF) Mass Spectrometry Systems for Identification of Yeasts of Medical Importance 65
Quantitation of Bacillus clausii in biological samples by real-time polymerase chain reaction 65
Human monoclonal recombinant antibody against NS3 HCV protein and methods therefor 64
Correspondence: Italy's policy shift on immunization 64
Intracytoplasmic stable expression of IgG1 antibody targeting NS3 helicase inhibits replication of highly efficient hepatitis C Virus 2a clone 64
Human monoclonal recombinant Fabs specific for HCV antigens obtained by repertoire cloning in phage display combinatorial vectors 63
Phage Display Technology 63
Monoclonal antibodies as a medicament for the therapeutic and/or prophylactic treatment of swine-origin influenza A (H1N1) virus (S-OIV) infections 63
Possible future monoclonal antibody (mAb)-based therapy against arbovirus infections 63
Blocking immunodominant epitopes by competitive deselection. 63
Enteric microbiome markers as early predictors of clinical outcome in allogeneic hematopoietic stem cell transplant (allo-HSCT): results of a prospective study in adult patients 63
CLONING AND CHARACTERIZATION OF HUMAN RECOMBINANT ANTIBODY FAB FRAGMENTS SPECIFIC FOR TYPE-1 AND TYPE-2 HERPES-SIMPLEX VIRUS 62
Definition of biological activity and quantitation of different families of human anti-HCV/E2 antibodies by generation of human recombinant anti-E2 monoclonal Fab by phage display combinatorial repertoire library 62
Evaluation of a synergistic interactions of anti-E2/HCV monoclonal antibodies 61
Hepatitis C virus (HCV)-driven stimulation of subfamily-restricted natural IgM antibodies in mixed cryoglobulinemia 61
Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs 60
Inhibition of HCV-NS3 helicase activity and negative strand RNA syntesis by intracelllular expression of a recombinant human anti-NS3 Fab 60
Dissection of the IgA1 local response by construction of isotype-specific combinatorial libraries displayed on the surface of phage from gastro-jejunal biopsies. 60
Molecular Diagnosis of Scedosporium apiospermum Keratitis. 60
Totale 9.604
Categoria #
all - tutte 85.940
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.940


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022135 0 0 0 41 6 3 17 14 6 27 7 14
2022/20231.104 387 281 95 11 11 135 48 56 55 3 14 8
2023/2024530 24 38 79 62 29 100 11 43 4 38 19 83
2024/20252.405 292 34 45 131 72 225 354 217 430 273 154 178
2025/20267.775 608 629 805 1.149 526 254 640 532 2.051 332 121 128
2026/20271.737 283 397 411 646 0 0 0 0 0 0 0 0
Totale 13.838